Ben Emery, Ph.D.
Assistant Professor of Neurology, Oregon Health & Science University
Dr. Emery received his Ph.D. and B.S. degrees from the University of Melbourne and completed his postdoctoral research at Stanford University. His postdoctoral work focused on defining gene expression across the different cell types of the brain and using this information to identify novel genes involved in myelination. Through this work, he identified a transcription factor (now known as Myrf) as a critical regulator of oligodendrocyte development and myelination. His lab at Oregon Health and Science University (OHSU) has since leveraged this work to use mutant mouse line for the Myrfgene as tools to better understand demyelinating disease, with a particular focus on remyelination and on axonal degeneration. Dr. Emery is the recipient of several awards, including the Australian Neuroscience Society A.W. Campbell Award, the Australian Institute of Policy and Science Victorian Tall Poppy Award and the American Anatomical Association Young Investigators Award in Morphological Sciences. He is a member of the editorial board for Glia and a review committee member for the National Multiple Sclerosis Society.